Search research articles
Contact Us
Filters
Showing results (171-180 of 238) with videos related to
Page
of 24
Sort By:
Nature Medicine
|
January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
The New England Journal of Medicine
|
October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemia
Shannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Blood Advances
|
June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry
Samuel John, Kevin J Curran, Erin M Hall, et al.
Blood
|
November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy
Haley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine
|
June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
Haydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
Blood
|
September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
Shannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
Karen Thudium Mueller, Edward Waldron, Stephan A Grupp, et al.
Nature Reviews. Clinical Oncology
|
January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells
Haneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 238) with videos related to
Sort By:
Page
of 24
Nature Medicine
|
January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
The New England Journal of Medicine
|
October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemia
Shannon L Maude, Noelle Frey, Pamela A Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Blood Advances
|
June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry
Samuel John, Kevin J Curran, Erin M Hall, et al.
Blood
|
November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy
Haley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine
|
June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
Haydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
Blood
|
September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
Shannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
Karen Thudium Mueller, Edward Waldron, Stephan A Grupp, et al.
Nature Reviews. Clinical Oncology
|
January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells
Haneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Page
of 24